Senate Bill Would Exempt Low-Risk Apps From FDA Oversight
This article was originally published in The Gray Sheet
Executive Summary
The MEDTECH Act aims to limit FDA’s regulatory oversight of software and mobile apps that carry low-risk for patients, but in a more targeted manner than previous health IT bills that have been introduced in Congress in the past year.